about
Invariant NKT cells as novel targets for immunotherapy in solid tumorsCD1d- and MR1-Restricted T Cells in SepsisCD1d-expressing breast cancer cells modulate NKT cell-mediated antitumor immunity in a murine model of breast cancer metastasis.Altered development of NKT cells, γδ T cells, CD8 T cells and NK cells in a PLZF deficient patient.NKT cells in sepsis.CD1d-based combination therapy eradicates established tumors in mice.Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: reversing tumor-induced defects.Delicate balance among three types of T cells in concurrent regulation of tumor immunity.A double-edged sword: the role of NKT cells in malaria and HIV infection and immunity.Targeting natural killer cells and natural killer T cells in cancer.Immunomodulatory type II natural killer T lymphocytes in health and disease.Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.Direct CD1d-mediated stimulation of APC IL-12 production and protective immune response to virus infection in vivo.Natural Killer T Cells in Cancer ImmunotherapyNKT Cell Hyporesponsiveness Leads to Unrestrained Accumulation of Marginal Zone B Cells in Hypercholesterolemic Apolipoprotein E-Deficient Mice.Neurofibromin 1 Impairs Natural Killer T-Cell-Dependent Antitumor Immunity against a T-Cell Lymphoma.
P2860
Q21284987-355160AB-0629-43B5-A17F-5339EC6775C9Q26796132-F5C0DE6F-DA5E-42E9-B386-F687FF4D6E0EQ33939552-A1FADBFF-6FB6-4AB2-B693-3CEE52413BFFQ34019039-87DFEA4E-AA14-4C47-A47A-904A85E8086BQ34189487-B30BE0D4-9CEE-4316-80D7-D2FC1B932C7FQ34257887-23D27E06-3957-4673-BAB0-116279E1D297Q35127172-B5F5E351-196B-4660-8B47-F92D0921B1A8Q36755513-84888EEC-B7B1-4565-A235-1072170D356EQ37644961-A4555693-AEC5-4C85-8B8C-BC1A9881486FQ37995950-80BC3490-100F-4CB9-9B58-8095102691AFQ38020906-C9143FAF-72F2-456F-B186-B4C877A3B403Q38894017-111CF522-E8D9-4929-B581-6BED30FDD132Q41858795-10C475B1-C456-413A-A9A3-FDB32738ED7BQ42078314-0FF9C1A1-6BAD-4ACC-93F7-C42B74608CA6Q48261376-875066EF-947D-44C9-8A5F-599A3395A05FQ49331836-09262C6A-803D-46E9-A795-52AD88647775
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
CD1d activation and blockade: a new antitumor strategy
@ast
CD1d activation and blockade: a new antitumor strategy
@en
CD1d activation and blockade: a new antitumor strategy
@nl
type
label
CD1d activation and blockade: a new antitumor strategy
@ast
CD1d activation and blockade: a new antitumor strategy
@en
CD1d activation and blockade: a new antitumor strategy
@nl
prefLabel
CD1d activation and blockade: a new antitumor strategy
@ast
CD1d activation and blockade: a new antitumor strategy
@en
CD1d activation and blockade: a new antitumor strategy
@nl
P2093
P2860
P356
P1476
CD1d activation and blockade: a new antitumor strategy
@en
P2093
Janelle Sharkey
Michele W L Teng
P2860
P304
P356
10.4049/JIMMUNOL.0802964
P407
P577
2009-03-01T00:00:00Z